{"certainAgreement":{"otherDetails":"MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"information.center@astrazeneca.com","organization":"MedImmune, LLC","phone":"+1-650-264-9079","title":"Priti Patel"}}